PG-11047 2HCl NEW
| Price | $67 | $201 | $322 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-11-02 |
Product Details
| Product Name: PG-11047 2HCl | Purity: 97.47% |
| Supply Ability: 10g | Release date: 2025/11/02 |
Product Introduction
Bioactivity
| Name | PG-11047 2HCl |
| Description | PG-11047 2HCl is an apoptosis-stimulating agent used in the treatment of genitourinary disorders, immune system disorders, genetic disorders and malformations, ocular disorders, and disorders of the blood and lymphatic systems, and in the study of lymphomas and prostate cancer. |
| In vitro | PG-11047 2HCl (13 nM-5 mM; 72 h) inhibits the growth of members of a broad range of mammary cell lineages, with basal-like cell lines being inhibited at lower concentrations than luminal cell lines.[1] PG-11047 2HCl (0.3, 10, 300 μM; 48 h, 72 h) shows a significant reduction in S-phase fraction at doses that produce little apoptosis.[1] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 4.62 mg/mL (14.01 mM), Sonication is recommended. |
| Keywords | PG-11047 2HCl | PG-11047 | PG11047 | PG 11047 | CGC-11047 | CGC11047 | CGC 11047 | Apoptosis |
| Inhibitors Related | Stavudine | 5-Fluorouracil | Flubendazole | Cysteamine hydrochloride | Myricetin | Sodium 4-phenylbutyrate | L-Ascorbic acid | L-Glutamic acid | Tributyrin | L-Ascorbic acid sodium salt | Alginic acid | Dextran sulfate sodium salt (MW 5000) |
| Related Compound Libraries | Apoptosis Compound Library | Bioactive Compound Library | Hematonosis Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Anti-Prostate Cancer Compound Library | Immunology/Inflammation Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1770.00/50mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-10-27 | |
| $0.00/10mg |
VIP8Y
|
Guangzhou PI PI BIOTECH INC
|
2022-04-23 | |
| $98.00/2mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-07-22 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY